<html>
<head>PUBMED IDs for NEK9</head>
<body bgcolor='#C5F0F2'><h1>NEK9</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21955398/'>Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.</a> April 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23132929/'>Cell cycle regulation by the NEK family of protein kinases.</a> April 27  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25131192/'>NEK9-dependent proliferation of cancer cells lacking functional p53.</a> November 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25217585/'>A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response.</a> January 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26908619/'>Recessive NEK9 mutation causes a lethal skeletal dysplasia with evidence of cell cycle and ciliary defects.</a> February 26  2016<br></body></html>
